Related by context. All words. (Click for frequent words.) 74 IND submission 74 BLA submission 74 MAA submission 73 Biologic License Application BLA 72 Phase #b/#a 72 RIGScan CR 72 Phase Ib study 71 Voraxaze 71 ENRICH trial 71 sNDA submission 71 PMA submission 71 PANVAC VF 71 GLP toxicology studies 71 ruxolitinib 71 NEBIDO 70 NDA resubmission 70 SILENOR 70 rALLy trial 70 FDA approvable letter 70 Hedgehog antagonist 70 registrational 70 confirmatory Phase III 69 SUCCEED trial 69 Plicera 69 CIP TRAMADOL ER 69 PRECISE trial 69 Phase IIb clinical trials 69 Civacir 69 Allovectin 7 69 IIa trial 69 FDA Approvable Letter 69 Orathecin 69 Urocidin 69 CRMD# 69 AERx iDMS 69 PREOS R 69 CLIRS trial 69 phase IIb trial 68 initiate Phase IIb 68 Phase IIb trials 68 Phase lll 68 forodesine 68 Surfaxin LS 68 Zenvia ™ 68 ACCLAIM II 68 OMAPRO 68 UPLYSO 68 Biologics License Application BLA 68 POSIDUR TM 68 PRECISE Trial 68 PREOS 68 IND Investigational New 68 LibiGel NDA 68 indiplon capsules 68 Telatinib 68 Q#IR 68 oral methylnaltrexone 68 NDA submission 68 nalbuphine ER 68 trastuzumab DM1 T DM1 68 zileuton CR 67 Dacogen injection 67 GALNS 67 Somatuline R Autogel R 67 Marketing Authorisation Application MAA 67 Marketing Authorisation Application 67 SILENOR TM 67 Phase IIIb clinical 67 faropenem 67 OFIRMEV 67 ZEGERID Capsules 67 Pre IND 67 Dyloject TM 67 Marketing Authorization Application 67 oral ridaforolimus 67 Phase IIB 67 TOCOSOL Paclitaxel 67 balsalazide tablet 67 T Pred 67 PDE4 inhibitor 67 Phase Ib II 67 confirmatory Phase 3 67 Prestara TM 67 Phase III TRIST 67 Cimzia TM 67 ATryn R 67 maribavir 67 OvaRex R 67 DPX Survivac 67 lorcaserin NDA 67 OvaRex ® MAb 67 Troxatyl 67 Icatibant 67 Biologics License Application 67 Biological License Application 67 phase IIa 67 Hematide ™ peginesatide 67 Fodosine 67 Archexin 67 IL# PE#QQR 67 BrachySil TM 66 SPARLON 66 Phase 2a clinical trials 66 MoxDuo IR 66 Phase III HEAT 66 Trobalt 66 pivotal bioequivalence 66 Evoltra TM 66 Flutiform ™ 66 Panzem R NCD 66 Spiegelmer ® 66 octreotide implant 66 CHMP recommendation 66 Complete Response 66 Alzhemed TM 66 AZD# TC 66 tramiprosate Alzhemed TM 66 Marketing Authorization Application MAA 66 Premarket Approval PMA 66 oxymorphone ER 66 phase IIa clinical 66 ELACYT 66 IMA# 66 Centralized Procedure 66 elotuzumab 66 Glybera R 66 SNT MC# 66 ATryn ® 66 BEMA Granisetron 66 TBC# 66 SUTENT ® 66 hoFH 66 AZILECT ® 66 Linjeta TM 66 successfully commercialize Iluvien 66 ONCONASE R 66 phase IIb 66 Nebido 66 phase IIb clinical 66 alvespimycin 66 omacetaxine mepesuccinate 66 generation purine nucleoside 66 Intermezzo ® NDA 66 Omigard 66 ANTEGREN 65 Phase IIa trials 65 Files Investigational 65 torezolid phosphate 65 Zensana 65 FORTIS M trial 65 ponatinib 65 Phase 1a clinical 65 Allovectin 7 r 65 vidofludimus 65 Neo Kidney Augment 65 severe hypercholesterolemia 65 Kamada AAT 65 SILENOR ™ 65 liprotamase 65 CINTREDEKIN BESUDOTOX 65 Extina 65 Nabi HB Intravenous 65 Premarket Approval Application 65 Trofex 65 Urocidin TM 65 zileuton IV 65 LibiGel ® 65 pradefovir 65 BRILINTA 65 Plenaxis R 65 AzaSite Plus 65 sNDA filing 65 Corlux 65 OMNARIS Nasal Spray 65 MONOVISC 65 brivaracetam 65 WILEX 65 alglucosidase alfa 65 Evoltra 65 Stimuvax R 65 Cloretazine ® 65 Androxal ® 65 Firazyr 65 PIX# trial 65 Luveniq 65 Cellegesic 65 cannabinor 65 Zenvia Phase III 65 Angiox ® 65 CIP ISOTRETINOIN 65 FDA Complete Response 65 acyclovir Lauriad R 65 dalbavancin 65 registrational trial 65 NADiA ProsVue 65 ISTODAX 65 initiate Phase 2a 65 EOquin 65 Memryte 65 BRIM3 65 Phenoptin 65 Zemiva TM 65 Rhucin R 65 midstage trials 65 Anturol TM 65 Ketotransdel 65 Viramidine 65 Acetavance TM 65 Acetavance 65 Plenaxis TM 65 preclinical toxicology 65 nonclinical studies 65 URG# 65 LidoPAIN SP 65 Alvesco R 65 Approvable letter 65 confirmatory pivotal 65 deforolimus 65 Panzem R 65 eniluracil 65 ATL# [001] 65 histamine dihydrochloride 65 postoperative ileus POI 65 Ceplene TM 65 Emezine 65 NDA Submission 65 Phase III Clinical Trial 65 Contrave NDA 65 Camvia 65 Preos 65 Genz # 65 BioSTAR R 65 MAXY VII 65 Amigal 65 inhaled AAT 65 ITAX 65 bardoxolone 64 PrevOnco ™ 64 pharmacokinetic PK study 64 Nuvion 64 APF# NDA 64 generic Copaxone 64 Phase 2b trial 64 PREGNANT Study 64 Mr. Bentsur 64 Glybera 64 Bicifadine 64 MOZOBIL 64 initiate Phase Ib 64 FOLOTYN ® 64 Pivotal Trial 64 Phase IIa trial 64 novel oral anticoagulant 64 OvaDx 64 Prosaptide 64 Flutiform TM 64 StaphVAX R 64 Premarket Approval 64 clinical pharmacology studies 64 Troxatyl TM 64 M Enoxaparin 64 oral prodrug 64 JAK inhibitor 64 MAXY alpha 64 Pivotal Phase III 64 Phase IIb III 64 BEMA TM Fentanyl 64 initiate Phase 2b 64 Urocortin 2 64 initiated Phase Ib 64 MAGE A3 ASCI 64 alvimopan 64 VALSTAR 64 IMC #B 64 PLK1 SNALP 64 Pruvel 64 Rhucin 64 granted Ortec 64 phase IIb study 64 VALOR trial 64 Virulizin R 64 talactoferrin 64 Soliris TM eculizumab 64 eTag assays 64 investigational humanized monoclonal antibody 64 budesonide MMX Phase III 64 lomitapide 64 TRANSDUR Bupivacaine 64 HuMax TAC 64 LymphoStat B TM 64 Phase #b/#a clinical 64 CytoFabTM 64 Saforis 64 Twinrix 64 RIGScan 64 Phase Ib 64 SPRYCEL ® 64 AMPAKINE CX# 64 ASONEP 64 Velcade bortezomib 64 Aurexis 64 Cintredekin besudotox 64 OraTest 64 OncoVEX 64 LEVADEX ™ 64 SinuNase ™ 64 ARIKACE ™ 64 Ereska 64 Visian Toric ICL 64 Diamyd ® 64 Uvidem 64 SYCREST 64 SURFAXIN 64 PROVENGE sipuleucel T 64 Exherin TM 64 Phase 2a trial 64 INCB# [001] 64 vosaroxin 64 Bioral Amphotericin B 64 Biologic License Application 64 LE SN# 64 Tracleer r 64 Triapine R 64 Japanese Encephalitis vaccine 64 Personalized Immunotherapy 64 Altastaph 64 THALOMID 64 Octreolin 64 TRISENOX 64 Androxal TM 64 EVIZON TM 64 JOULFERON 64 TELINTRA 64 Voraxaze ™ 64 Rhucin ® 64 Frova ® 64 herpetic keratitis 64 QTinno TM 64 OLpur TM H2H 64 alemtuzumab MS 64 Zelrix 64 OMNARIS HFA 64 OMAPRO ™ 64 HepeX B 63 tanespimycin 63 Allovectin 7 ® 63 please visit www.advaxis.com 63 supplemental Biologics License Application 63 Virulizin ® 63 Phase #b/#a trial 63 PROVENGE ® 63 Allovectin 7 R 63 BiDil XR 63 SYMMETRY trial 63 Rescula 63 Phase #/#a trial 63 rALLy clinical trial 63 naronapride 63 approvability 63 relapsed MCL 63 teduglutide 63 Advagraf 63 tezampanel NGX# 63 supplemental biologics 63 Evoltra ® 63 TOLAMBA 63 Vernakalant 63 triphendiol 63 BCX# 63 compound INCB# 63 YONDELIS 63 Proellex TM 63 Oglemilast 63 Zemplar Capsules 63 tiapamil 63 HuMax CD4 63 Chemophase 63 PDX pralatrexate 63 Phase III pivotal 63 BENLYSTA 63 oral salmon calcitonin 63 lucinactant 63 Marketing Authorization Applications 63 MEND CABG II 63 IIb clinical trial 63 Xcytrin R 63 BrachySil 63 EndoTAG TM -1 63 PDUFA date 63 Ceflatonin 63 ATPace 63 CLIA waiver 63 generation URAT1 inhibitor 63 JZP 63 APTIMA HPV assay 63 Hematide ™ 63 oral picoplatin 63 alogliptin 63 intravenous acetaminophen 63 tramiprosate ALZHEMED TM 63 Evoltra R 63 sNDAs 63 ospemifene 63 Restanza 63 enzastaurin 63 PEG PAL 63 novel therapeutic antibodies 63 Azedra TM 63 budesonide foam 63 Asentar 63 dose escalation phase 63 IND enabling 63 Phase 1b trial 63 Targretin capsules 63 Dextofisopam 63 Tesmilifene 63 Aphthasol R 63 faropenem medoxomil 63 Fibrillex TM 63 Aurora kinase inhibitor 63 ATIR 63 Bonefos 63 Harry Palmin President 63 FIRAZYR 63 ritonavir boosted danoprevir 63 tezampanel 63 Hedgehog Pathway Inhibitor 63 Simulect 63 PrevOnco 63 sBLA 63 anticancer compound 63 Phase 2b study 63 Sulonex TM 63 Loramyc 63 SAR# [004] 63 Omapro 63 glucokinase activator 63 unblinding 63 tolevamer 63 prGCD 63 rhFVIIa 63 Ocrelizumab 63 MyVax 63 phase Ib 63 EGS# 63 CEQ# 63 CONBRIZA 63 Complete Response letter 63 lumiliximab 63 PNP inhibitor 63 Potelligent Technology 63 RhuDex ® 63 Kynapid 63 cystinosis patients 63 phase IIb III 63 Annamycin 63 CAMPATH 63 Xanafide 63 Panzem ® 63 BENLYSTA ® 63 anidulafungin 63 bosutinib 63 rPA anthrax vaccine 63 Benlysta belimumab 63 squalamine 63 ganetespib 63 Quinamed 63 AZX# 63 huC# DM4 63 GED aPC 63 preclinical pharmacokinetic 63 Manja Bouman CEO 63 Onalta ™ 63 Hectorol R 63 EDEMA4 63 Veronate 63 Stedivaze 63 Nexavar sorafenib 63 ATPace TM 63 Phase 1b clinical trials 63 Zensana TM 63 QNEXA 63 PSMA ADC 63 sumatriptan DosePro 63 KIACTA ™ 62 RSD# oral 62 Loramyc R 62 Oracea TM 62 Elagolix 62 Submits Response 62 carcinogenicity study 62 MethyPatch 62 TAXUS Element Stent System 62 alemtuzumab Campath 62 Auxilium Pharma 62 CCX# 62 Stavzor 62 EDEMA3 62 Oncotype DX colon cancer 62 cathepsin K inhibitor 62 CDP# 62 IV APAP 62 PHX# 62 methylnaltrexone 62 PF # [002] 62 #D#C# 62 LibiGel Phase III 62 GATTEX TM 62 Onrigin 62 Phase III trials 62 Thorough QT 62 Phase IIa clinical trials 62 Neuradiab 62 Iluvien ® 62 confirmatory clinical 62 XmAb# 62 Lymphoseek ® 62 thorough QT 62 gepirone ER 62 LUMINATE 62 PDE# inhibitors 62 ReN# 62 Keppra ® XR 62 Zingo TM 62 VITAL Trial 62 KRYSTEXXA TM pegloticase 62 orBec 62 Firazyr ® 62 opioid induced bowel dysfunction 62 MVax 62 Somatuline Autogel 62 PEG SN# 62 MERLIN TIMI 62 Drug Eluting Stent System 62 Temsirolimus 62 IV acetaminophen 62 ICA # 62 Alnylam #x# 62 Marqibo 62 Investigational Device Exemption 62 LEUKINE 62 XP# XP# 62 BEMA Fentanyl 62 EDEMA3 trial 62 Lauren Silvernail 62 tubulin inhibitor 62 eliglustat tartrate 62 Actimmune ® 62 miconazole Lauriad ® 62 Onyx Pharma 62 INT# [002] 62 Ruconest 62 Fabry Disease 62 proprietary transdermal patch 62 Phase 1a 62 StemEx 62 ALN HTT 62 refractory chronic lymphocytic 62 Tarceva TM 62 lorcaserin Phase 62 Orapred ODT 62 Phase III confirmatory 62 UVIDEM 62 KNS # 62 sNDA 62 epigenetic therapies 62 HuMax EGFr 62 FACTIVE tablets 62 candidates Dyloject TM 62 AMEVIVE 62 Provecta 62 Study #CL# 62 Immunotherapeutic 62 immatics 62 initiate Phase 1b 62 candidate CRLX# 62 dose cohort 62 IND Filing 62 BEXXAR 62 immunotherapeutic vaccine 62 DEB# 62 FIRMAGON R 62 Zenpep 62 Valtropin 62 SparVax TM 62 ZOLINZA 62 Zerenex 62 ADVANCE PD 62 XL# anticancer compounds 62 TLK# 62 atacicept 62 mertansine 62 Combidex 62 ularitide 62 OLEPTRO 62 Optiquel ™ 62 Cutanea 62 PNT# 62 trastuzumab DM1 62 Solorel 62 LEP ETU 62 Technosphere Insulin 62 incyclinide 62 EXPAREL ™ 62 QRxPharma 62 Neovasc Reducer 62 IND CTA 62 Factor VIIa 62 Onsolis 62 Eligard ® 62 Fx #A 62 HDL Selective Delipidation 62 Huntexil 62 DCVax R 62 Mepact 62 Anavex #-# 62 Biologics Licensing 62 hypoxia activated prodrug 62 ORENCIA R 62 EmbraceAC 62 NEUMUNE 62 GAMMAGARD 62 omega interferon 62 FavId 62 Entereg R 62 ONSOLIS 62 Phase IIb trial 62 dexanabinol 62 PA# [002] 62 AeroLEF TM 62 clevidipine 62 Preotact 62 IRX 2 62 Vilazodone 62 ENMD # 62 VIVITROL ® 62 OVATURE 62 NV1FGF 62 midstage studies 62 MyVax R 62 StemEx R 62 Phase III Clinical Trials 62 AZILECT R 62 Linjeta 62 Pirfenidone 62 HCD# [002] 62 AVAX 62 Velac 62 GTC recombinant human 62 lintuzumab 62 rhThrombin 62 randomized Phase 2b 62 autologous cellular immunotherapy 62 OraTest R 62 eprodisate KIACTA TM 62 Joulferon 62 oral taxane 62 eprodisate Fibrillex TM 62 TOCOSOL Camptothecin 62 subsidiaries visit http:/www.apricusbio.com 62 Protexia ® 62 Junovan 62 NP2 Enkephalin 62 Certican 62 Lucanix R 62 Torisel 62 submit Biologics License 62 Aryplase 62 Ambrisentan 61 ALN PCS 61 Onconase 61 MEK inhibitor RDEA# 61 pralatrexate 61 ENTEREG ® 61 AIMM trial 61 Shigamabs ® 61 novel trazodone formulation 61 investigational therapies 61 rThrombin 61 Kiadis Pharma 61 Phase III 61 CAPHOSOL 61 Prodarsan 61 BCR ABL inhibitor 61 novel histone deacetylase 61 Marketing Authorisation 61 Trofex TM 61 antibody MAb 61 Silodosin 61 SinuNase TM 61 including eniluracil ADH 61 ESTRASORB 61 refractory APL 61 Phase #/#a 61 L BLP# 61 NeuVax 61 Trovax 61 Degarelix 61 CryoSeal 61 docetaxel Taxotere R 61 PROSTVAC TM 61 Application BLA 61 generic Lovenox 61 Octreotide 61 mifamurtide 61 Capesaris 61 Lupuzor 61 molecular imaging radiopharmaceutical 61 BNC# 61 ENDEAVOR IV 61 Phase III clinical 61 adenosine injection 61 lorvotuzumab mertansine 61 COMFORT II 61 Phase III LibiGel 61 aurora kinase 61 Firdapse 61 Soliris eculizumab 61 adjuvant GIST 61 novel emulsion formulation 61 REBETOL combination therapy 61 Prestara 61 ARISE Phase III 61 Initiate Clinical Trial 61 ORBIT II 61 apricitabine ATC 61 Pegloticase 61 LibiGel ® testosterone gel 61 Aflibercept 61 MOVIPREP R 61 AzaSite TM 61 G#DT 61 AQ4N 61 iclaprim 61 Phase IIIb study 61 CCR9 antagonist 61 VTE prevention 61 BLOOM DM 61 Orazol 61 Genasense ® 61 Amrubicin 61 Augment Injectable 61 TMC# [002] 61 bazedoxifene 61 sapacitabine 61 vemurafenib 61 ticagrelor Brilinta 61 ADVEXIN clinical 61 STRIDE PD 61 website http:/www.celsion.com 61 Thelin tm 61 Oncoscience AG 61 Fast Track Status 61 Retacrit 61 TroVax ® 61 obatoclax 61 HGS# 61 file INDs 61 PDUFA Date 61 sargramostim 61 pexiganan 61 DXL# 61 Phase Ib clinical 61 ridaforolimus 61 Aplidin 61 Menerba 61 StaphVAX 61 Chimigen TM 61 PRT# 61 Protexia R 61 Cinryze ™ 61 Zavesca r 61 APEX AMI trial 61 MelaFind R 61 topical ophthalmic 61 TRIST study 61 L MTP PE 61 ACUROX 61 Bifeprunox 61 HQK 61 TEMODAL 61 Phase Ib IIa 61 OncoVEX GM CSF 61 APPRAISE 61 CRD5 61 ozarelix 61 MEND CABG 61 Roflumilast 61 ANCHOR trial 61 Orphan Status 61 metastatic sarcomas 61 sumatriptan injection 61 tafamidis 61 Panzem 61 APF# 61 MGN# 61 heterozygous FH 61 midstage clinical 61 evaluating satraplatin 61 ATL/TV# 61 Somatuline R Depot 61 Raptiva ® 61 punctal plug 61 VitiGam 61 Generx ™ 61 Phase IIb 61 Pivotal Clinical Trial 61 HuLuc# 61 investigational antiplatelet agent 61 budiodarone 61 OLEPTRO TM 61 MGd 61 pafuramidine 61 Genzyme Myozyme 61 Completes Patient Enrollment 61 EVIZON TM squalamine lactate 61 Zybrestat 61 sitaxsentan 61 TRO# 61 liver resection surgeries 61 Shigamabs 61 plasma kallikrein inhibitor 61 Ixempra 61 phase Ib clinical 61 GENASIS trial 61 vaginal lidocaine 61 DR Cysteamine 61 axitinib 61 CMV vaccine 61 ZEGERID Chewable Tablets 61 HEPLISAV ™ 61 Multiferon R 61 CIMZIA TM 61 APTIVUS 61 PEARL SC 61 bevasiranib 61 Loramyc TM 61 MAXY G# 61 Aloxi injection 61 unblind 61 Fast Track Designation 61 SEPET TM 61 HepaGam B 61 PROMACTA CARES 61 neratinib 61 Phase 2b clinical 61 R#/MEM # 61 Phase III ADT 61 R#/MEM 61 JAK2 Inhibitor 61 Vectibix panitumumab 61 LEVADEX TM 61 EOquin TM 61 leading oral taxane 61 Mipomersen 61 candidate TNFerade biologic 61 CoFactor 61 tasimelteon 61 Canvaxin TM 61 severe gastroparesis 61 PTK ZK 61 FM VP4 61 Anturol ® 61 APEX AMI 61 PRIMO CABG 61 Avastin adjuvant 61 bicifadine 61 basal insulin analogue 61 Bezielle 61 Regeneron Pharma 61 application sNDA 61 AAG geldanamycin analog 61 MyVax personalized immunotherapy 61 Egrifta 61 CINQUIL 61 BioSante LibiGel Phase III 61 FluINsure 61 postapproval 61 IIa trials 61 ulimorelin 61 GRNVAC1 61 omiganan 61 personalized immunotherapy 61 Pafuramidine 61 Lovaxin C 61 Orphan Drug status 61 Initiate Phase II 61 ENZON 61 oral rivaroxaban 61 clinicaltrials 61 Arzerra ofatumumab 61 dimebon latrepirdine 61 INCB# [002] 61 Alferon N 61 Reverset 61 Prodarsan R 61 pain palliation 61 Silenor NDA 61 Tezampanel 61 testosterone gel LibiGel 61 Trastuzumab DM1 61 Begins Dosing 61 Cimzia ® certolizumab pegol 61 evaluating mipomersen 61 aerosolized surfactant 61 CHMP opinion 61 LUCASSIN 61 trastuzumab emtansine T DM1 61 Confirmatory 61 oral deforolimus 61 cMET 61 Phase 2b Clinical Trial 61 Viprinex TM 61 dirucotide 61 Cerepro ® 61 MelaFind ® 61 Esbriet pirfenidone 61 transmucosal delivery system 61 ezogabine 61 Dalbavancin 61 intranasal formulation 61 vilazodone 61 dextromethorphan quinidine 61 Proxinium TM 61 OncoGel 61 Tamibarotene 61 eprotirome 60 ALN TTR 60 Fibrillex 60 oxaliplatin Eloxatin 60 USL# 60 EGRIFTA TM 60 otelixizumab 60 AP# [003] 60 CIMZIA ™ 60 HoFH 60 Tectin TM 60 desvenlafaxine 60 ATL# [002] 60 HuCAL antibodies 60 Dendreon Provenge 60 ALGRX 60 GRAVITAS trial 60 Genasense ® oblimersen 60 RH1 60 next generation URAT1 60 Azedra ™ 60 ProSavin 60 ixabepilone 60 Canvaxin 60 non nucleoside HCV 60 Hepatocellular Carcinoma HCC 60 Ophena TM 60 receptor tyrosine kinase inhibitor 60 MKC# MKC# PP 60 ThermoDox R 60 ACAPODENE 60 PROSTASCINT R 60 CR# vcMMAE 60 Phase IIb clinical 60 Azedra 60 ADVEXIN p# therapy 60 HepeX B TM 60 PFO migraine 60 CUSTOM III 60 vivo glucose 60 DIFICID ™ 60 Bioaccelerate compounds under 60 Solazed 60 Excellagen 60 rPA vaccine candidate 60 CVac 60 NUEDEXTA ™ 60 RSR# 60 Clinuvel 60 PEP# [003] 60 Solasia 60 GLPG# 60 DSMB recommended 60 Cangrelor 60 Pixuvri 60 New Drug Application 60 TORISEL 60 HEPLISAV TM 60 XOMA 3AB 60 MyVax ® 60 mTOR inhibition 60 ARCOXIA 60 Phase 2b clinical trials 60 Emselex 60 AdreView 60 nasal bepotastine 60 RAPTIVA R 60 Sopherion 60 CTAP# Capsules 60 CB2 selective receptor agonist 60 ZEVALIN ® 60 Diamyd R 60 Fibrin Pad